|
|
|
|
| LEADER |
02398nmm a2200577 u 4500 |
| 001 |
EB000925082 |
| 003 |
EBX01000000000000000718678 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
150128 ||| eng |
| 020 |
|
|
|a 9781451951189
|
| 100 |
1 |
|
|a Nedde, Ellen
|
| 245 |
0 |
0 |
|a U.S. Health Care Reform
|c Ellen Nedde
|
| 260 |
|
|
|a Washington, D.C.
|b International Monetary Fund
|c 1993
|
| 300 |
|
|
|a 31 pages
|
| 651 |
|
4 |
|a United States
|
| 653 |
|
|
|a Insurance companies
|
| 653 |
|
|
|a Health
|
| 653 |
|
|
|a Institutional Investors
|
| 653 |
|
|
|a Pension Funds
|
| 653 |
|
|
|a Analysis of Health Care Markets
|
| 653 |
|
|
|a Finance
|
| 653 |
|
|
|a Public finance & taxation
|
| 653 |
|
|
|a National Government Expenditures and Health
|
| 653 |
|
|
|a Industries: Financial Services
|
| 653 |
|
|
|a Financial institutions
|
| 653 |
|
|
|a Health care spending
|
| 653 |
|
|
|a Financial Instruments
|
| 653 |
|
|
|a Regulation
|
| 653 |
|
|
|a Expenditure
|
| 653 |
|
|
|a Non-bank Financial Institutions
|
| 653 |
|
|
|a Health care
|
| 653 |
|
|
|a Health systems & services
|
| 653 |
|
|
|a Expenditures, Public
|
| 653 |
|
|
|a Health care reform
|
| 653 |
|
|
|a Public Health
|
| 653 |
|
|
|a Health Policy
|
| 653 |
|
|
|a Actuarial Studies
|
| 653 |
|
|
|a Public Finance
|
| 653 |
|
|
|a Health: Government Policy
|
| 653 |
|
|
|a Insurance Companies
|
| 653 |
|
|
|a Insurance
|
| 653 |
|
|
|a Insurance & actuarial studies
|
| 653 |
|
|
|a Medical care
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b IMF
|a International Monetary Fund
|
| 490 |
0 |
|
|a IMF Working Papers
|
| 028 |
5 |
0 |
|a 10.5089/9781451951189.001
|
| 856 |
4 |
0 |
|u https://elibrary.imf.org/view/journals/001/1993/093/001.1993.issue-093-en.xml?cid=1204-com-dsp-marc
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 330
|
| 520 |
|
|
|a High and rapidly rising health care costs in the United States and growing ranks of uninsured persons have brought health care reform to the top of the U.S. Administration’s policy agenda. This paper describes the health care financing system in the United States, highlights what are viewed as its most serious shortcomings, and explores possible reasons for high and rising medical care costs. After brief descriptions of alternative reform proposals, the paper discusses universal coverage under managed competition and its ability to deal with the equity and efficiency problems in the U.S. health care system
|